Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Here's to a Year of Compromise

January 1, 2012

The benefits of harmonization may be on industry's wish list, but buying into change is another story.

Global Economic Woes Overshadow Biotech Industry Advances in 2011

January 1, 2012

Greater emphasis on focus and efficiency for companies as market demands value in 2012.

Supporting Innovation Requires Consistency and Vision

December 1, 2011

Political leaders need to consider the impact of the biopharmaceutical industry on the economy.

Challenges and Innovations with Prefilled Syringes

September 2, 2011

Market considerations and new technologies must be recognized to achieve the full benefits of manufacturing prefilled syringes.

Navigating the Biosimilars Market

September 2, 2011

The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.

Q&A with Francis S. Collins

September 2, 2011

Inside the National Institutes of Health

Trends in Prefills

September 2, 2011

An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.

Top 1000 Global Biomanufacturing Facilities

August 1, 2011

Insights from real-time ranking of global biomanufacturing capabilities.

Efficient Multiproduct Process Development Case Study

August 1, 2011

Achieving multiproduct development within shortened timelines.

ADVERTISEMENT

ADVERTISEMENT

Click here